IMPLEMENTING THE GENERALIZED RISK-ADJUSTED COST-EFFECTIVENESS (GRACE) MODEL FOR SICKLE-CELL DISEASE: A CASE STUDY

被引：0
|
作者：
Kleintjens, J. [1 ]
Mulligan, K. [2 ]
Hassan, T. [3 ]
Land, N. [3 ]
May, S. G. [3 ]
Graf, M. [3 ]
机构：
[1] PRECISIONheor, London, England
[2] Univ Southern Calif, Los Angeles, CA USA
[3] PRECISIONheor, Los Angeles, CA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE466
引用
收藏
页码：S142 / S142
页数：1
相关论文
共 50 条
  • [31] THE PAINFUL CRISIS OF HOMOZYGOUS SICKLE-CELL DISEASE - A STUDY OF RISK-FACTORS
    BAUM, KF
    DUNN, DT
    MAUDE, GH
    SERJEANT, GR
    ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (07) : 1231 - 1234
  • [32] Cost-effectiveness analysis of implementing polygenic risk score in a workplace cardiovascular disease prevention program
    Mujwara, Deo
    Kintzle, Jen
    Di Domenico, Paolo
    Busby, George B.
    Botta, Giordano
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [33] THE COST-EFFECTIVENESS OF HYDROXYUREA FOR SICKLE CELL DISEASE AMONG CHILDREN IN SUB-SAHARAN AFRICA
    Rodriguez, Mauricio
    Ayers, Donald
    Bashal, Chanchal
    Mallow, Peter
    Niklewski, Paul
    PEDIATRIC BLOOD & CANCER, 2022, 69
  • [34] Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease
    Stallworth, James R.
    Jerrell, Jeanette M.
    Tripathi, Avnish
    AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (10) : 795 - 797
  • [35] Cost-Effectiveness of Erythrocytapheresis in Children and Young Adults with Beta Thalassemia Major and Sickle Cell Disease
    Van Hattem, Jessica
    Maes, Philip
    Esterhuizen, Tonya
    De Vos, Ann
    Ruppert, Martin
    van Heerden, Jaques
    BLOOD, 2023, 142
  • [36] Efficacy and Cost-Effectiveness of a Limited Phenotype Matching Transfusion Protocol for Children with Sickle Cell Disease
    Squires, Jerry E.
    Jyothi, Vinu
    Jackson, Sherron M.
    Abboud, Miguel
    Kalpatthi, Ram
    BLOOD, 2008, 112 (11) : 1046 - 1046
  • [37] Priapism in sickle-cell disease; incidence, risk factors and complications - an international multicentre study
    Adeyoju, AB
    Olujohungbe, ABK
    Morris, J
    Yardumian, A
    Bareford, D
    Akenova, A
    Akinyanju, O
    Cinkotai, K
    O'Reilly, PH
    BJU INTERNATIONAL, 2002, 90 (09) : 898 - 902
  • [38] The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation
    Cherry, M. G.
    Greenhalgh, J.
    Osipenko, L.
    Venkatachalam, M.
    Boland, A.
    Dundar, Y.
    Marsh, K.
    Dickson, R.
    Rees, D. C.
    HEALTH TECHNOLOGY ASSESSMENT, 2012, 16 (43) : 1 - +
  • [39] PREGABALIN FOR THE TREATMENT OF GENERALIZED ANXIETY DISORDERS (GAD) - A COST-EFFECTIVENESS CASE STUDY OF MEXICO
    Arreola-Ornelas, H.
    Rosado-Buzzo, A. A.
    Garcia-Mollinedo, M. D. L.
    Dorantes-Aguilar, J.
    Mould-Quevedo, J.
    Davila-Loaiza, G.
    VALUE IN HEALTH, 2009, 12 (03) : A176 - A176
  • [40] Negative Pressure Therapy for Complex Wounds in Patients with Sickle-Cell Disease: A Case Study
    Paggiaro, Andre Oliveira
    de Carvalho, Viviane Fernandes
    Fonseca, Guilherme Henrique Hencklain
    Doi, Allison
    Ferreira, Marcus Castro
    OSTOMY WOUND MANAGEMENT, 2010, 56 (08) : 62 - 67
12345